Author/Authors :
Velagic, V. University Hospital Centre Zagreb - Department for Cardiovascular Diseases, Croatia , Samardzic, Jure University of Zagreb - University Hospital Centre Zagreb, School of Medicine - Department for Cardiovascular Diseases, Croatia , Baricevic, Z. University Hospital Centre Zagreb - Department for Cardiovascular Diseases, Croatia , Skoric, B. University of Zagreb - University Hospital Centre Zagreb, School of Medicine - Department for Cardiovascular Diseases, Croatia , Cikes, M. University of Zagreb - University Hospital Centre Zagreb, School of Medicine - Department for Cardiovascular Diseases, Croatia , Gasparovic, H. University of Zagreb - School of Medicine, University Hospital Centre Zagreb - Department of Cardiac Surgery, Croatia , Biocina, B. University of Zagreb - School of Medicine, University Hospital Centre Zagreb - Department of Cardiac Surgery, Croatia , Milicic, D. University of Zagreb - University Hospital Centre Zagreb, School of Medicine - Department for Cardiovascular Diseases, Croatia
Abstract :
Heparin-induced thrombocytopenia is an immune-mediated serious adverse effect of heparin therapy. It is a relatively frequent complication among patients with mechanical circulatory support. Herein, we present a patient with severe heart failure and sepsis who developed heparin-induced thrombocytopenia shortly after implantation of left ventricular assist device as a bridge to transplantation and who was successfully treated with fondaparinux.
Keywords :
Heart failure , Heparin , induced thrombocytopenia , Sepsis , Ventricular assist device , Anticoagulation
